Obesity Featured Articles

31. Time, Trust, And Clarity: Rethinking Breast Cancer Trial Recruitment 10/19/2026

    Breast cancer trial recruitment faces narrow treatment windows, unclear communication, and uneven trust in information sources. Patients favor their treating physician, and one unexpected channel also earns their confidence.

32. Get Ready For Regulators With This Speed-Quality-Compliance Framework 10/19/2026

    Part two of a two-part series, experts Sapna Rani and Shaun Hastings offer a five-part framework to balance speed, quality, and compliance amid evolving clinical trial regulations.

33. The New Clinical Trial Regulatory Landscape Balances Speed, Quality, and Compliance — Are You Ready? 10/19/2026

    Part one of this two-part series explores how clinical trial regulation aims to balance speed, quality, compliance, and digital innovation.

34. The U.S. Clinical Trial Recruiting Pipeline – September 2026 10/16/2026

    This WhichTrial report breaks down which drug trials are growing the most and the least, drugs that are no longer being studied, and new drugs to the clinic from August to September.

35. Can Psychedelic‑Assisted Treatment Redefine Emotional Care In Oncology? 10/16/2026

    Psychedelic-assisted treatment may offer faster, lasting relief for cancer patients facing adjustment disorder, depression, and anxiety.

36. Beyond Healthcare Spending: The Evolving Definition Of Value In Health Policy 10/15/2026

    As pharmaceutical policy takes on more goals, success is harder to define. Value extends beyond spending, requiring evidence that expected benefits are realized.

37. Unlocking AI Value For Clinical Research Associates 10/15/2026

    Clinical research associates (CRAs) have largely been late to adopt AI. CRAs who adopt it can streamline repetitive work while also freeing capacity for high-judgment work.

38. For The Record: How Past Experience Enables Future Success 10/15/2026

    Launch counts and years in business prove a partner has delivered, but the better question is what was learned along the way and how much carries forward.

39. Compliance As A Service (CaaS): Scalable Engagement Model For Evolving Regulations And Technology In Life Sciences 10/14/2026

    Validation demand in life sciences rises and falls with system changes, audits, and deals. A subscription-style compliance model with human-led oversight of AI-enabled systems reframes validation as a standing capability.

40. Preparing Your ERP For Life Sciences Commercialization 10/14/2026

    Operational readiness for commercial launch starts well before approval. Four early decisions about timing, manufacturing model, validation, and partners shape whether clinical-stage systems can carry a commercial business.